Atlas Trials

Use of Endogenous Melatonin and 6-hydroxymelatonin as Biomarkers for CYP1A2

Clinical trial NCT04420611 · COMPLETED

Trial details

NCT number
NCT04420611
Sponsor
Youssef Daali
Status
COMPLETED
Study type
OBSERVATIONAL
Healthy
Start date
2020-10-01
Primary completion
2020-12-30
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.